N-(4-azido-2,3,5,6-tetrafluorobenzyl)-3-maleimidopropionamide: structure given in first source; a heterobifunctional photo-cross-linker [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 3035702 |
SCHEMBL ID | 14394441 |
MeSH ID | M0199203 |
Synonym |
---|
tfpam-3 |
n-[(4-azido-2,3,5,6-tetrafluorophenyl)methyl]-3-(2,5-dioxopyrrol-1-yl)propanamide |
1h-pyrrole-1-propanamide, n-((4-azido-2,3,5,6-tetrafluorophenyl)methyl)-2,5-dihydro-2,5-dioxo- |
n-(4-azido-2,3,5,6-tetrafluorobenzyl)-3-maleimidopropionamide |
139428-48-1 |
1h-pyrrole-1-propanamide,n-[(4-azido-2,3,5,6-tetrafluorophenyl)methyl]-2,5-dihydro-2,5-dioxo- |
SCHEMBL14394441 |
DTXSID60161040 |
FT-0736431 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |